Detalles de la búsqueda
1.
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
Invest New Drugs
; 42(1): 80-88, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38099989
2.
Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria.
Bioorg Med Chem Lett
; 26(13): 3148-3152, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27173797
3.
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.
Mol Cancer Ther
; 22(3): 333-342, 2023 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36808277
4.
Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics.
Pharmaceutics
; 14(6)2022 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35745730
5.
Novel Dual-Targeting Antibody Fragment IDB0062 Overcomes Anti-Vascular Endothelial Growth Factor Drug Limitations in Age-Related Macular Degeneration.
Transl Vis Sci Technol
; 10(14): 35, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967833
6.
Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers.
Drug Des Devel Ther
; 13: 2483-2490, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440032
7.
Quantification of IDP-73152, a novel antibiotic, in plasma from mice, rats and humans using an ultra-high performance liquid chromatography/tandem mass spectrometry method for use in pharmacokinetic studies.
J Pharm Biomed Anal
; 145: 364-371, 2017 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28715789
Resultados
1 -
7
de 7
1
Próxima >
>>